These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15763053)

  • 1. [Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: a randomized, controlled and double-blinded prospective trial].
    Feng YL; Ling CQ; Zhu DZ; Yu CQ; Chen Z; Li B
    Zhong Xi Yi Jie He Xue Bao; 2005 Mar; 3(2):99-102. PubMed ID: 15763053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on integrative medicine for preventing and treating post-transcatheter arterial chemoembolization].
    Feng YL; Ling CQ; Li B
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jun; 25(6):534-6. PubMed ID: 16025970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization.
    Yinglu F; Changquan L; Xiaofeng Z; Bai L; Dezeng Z; Zhe C
    J Altern Complement Med; 2009 Feb; 15(2):175-81. PubMed ID: 19216654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ginsenosides and dexamethasone in managing the liver injury and renal function after transcatheter arterial chemoembolization for hepatic carcinoma patient].
    Feng YL; Ling CQ; Chen Z; Li B; Gu W
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):844-7. PubMed ID: 17416007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin.
    Sakamoto T; Saito Y; Kobayashi M; Yamada T; Takekuma Y; Nakai M; Ogawa K; Iseki K; Sugawara M
    Support Care Cancer; 2020 Jul; 28(7):3251-3257. PubMed ID: 31732854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study.
    Yang H; Seon J; Sung PS; Oh JS; Lee HL; Jang B; Chun HJ; Jang JW; Bae SH; Choi JY; Yoon SK
    J Vasc Interv Radiol; 2017 Nov; 28(11):1503-1511.e2. PubMed ID: 28941589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization.
    Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Nagai K; Nakagawa T; Sugawara T; Hanaoka H; Kanai F; Yokosuka O
    Hepatology; 2018 Feb; 67(2):575-585. PubMed ID: 28746788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial.
    Pan Y; Chang R; He Z; Hong M
    Medicine (Baltimore); 2021 Apr; 100(14):e25360. PubMed ID: 33832116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xu L; Wang S; Zhuang L; Lin J; Chen H; Zhu X; Bei W; Zhao Q; Wu H; Meng Z
    Integr Cancer Ther; 2016 Sep; 15(3):349-57. PubMed ID: 26590124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization.
    Arslan M; Degirmencioglu S
    Curr Med Imaging Rev; 2019; 15(4):380-385. PubMed ID: 31989907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma.
    Zhou B; Yan Z; Liu R; Shi P; Qian S; Qu X; Zhu L; Zhang W; Wang J
    Radiology; 2016 Aug; 280(2):630-9. PubMed ID: 26885681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety analysis of dexamethasone + palonosetron in prevention of post-embolization syndrome after D-TACE: A retrospective study.
    Lu H; Zheng C; Liang B; Xia X
    Medicine (Baltimore); 2023 Oct; 102(40):e35433. PubMed ID: 37800841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
    Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial.
    Xie J; Chen LH; Ning ZY; Zhang CY; Chen H; Chen Z; Meng ZQ; Zhu XY
    Chin J Cancer; 2017 Jan; 36(1):6. PubMed ID: 28069044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase III Trial (CLOG1302 study).
    Zhang L; Qu X; Teng Y; Shi J; Yu P; Sun T; Wang J; Zhu Z; Zhang X; Zhao M; Liu J; Jin B; Luo Y; Teng Z; Dong Y; Wen F; An Y; Yuan C; Chen T; Zhou L; Chen Y; Zhang J; Wang Z; Qu J; Jin F; Zhang J; Jin X; Xie X; Wang J; Man L; Fu L; Liu Y
    J Clin Oncol; 2017 Nov; 35(31):3558-3565. PubMed ID: 28854065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies.
    Alvarez O; Freeman A; Bedros A; Call SK; Volsch J; Kalbermatter O; Halverson J; Convy L; Cook L; Mick K
    J Pediatr Hematol Oncol; 1995 May; 17(2):145-50. PubMed ID: 7749764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of bile duct injury after transcatheter arterial chemoembolization].
    Wang MQ; Shao RH; Ye HY; Wang ZQ; Wang ZP; Liu FY
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):609-12. PubMed ID: 16438871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nausea and vomiting after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.
    Wang SY; Zhu WH; Vargulick S; Lin SB; Meng ZQ
    Asian Pac J Cancer Prev; 2013; 14(10):5995-6000. PubMed ID: 24289614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards.
    Lucatelli P; Argirò R; De Rubeis G; Rocco B; Corradini SG; Corona M; Nardis PG; Saba L; Mennini G; Fiorentino F; Corsi A; Catalano C; Bezzi M
    J Vasc Interv Radiol; 2019 Mar; 30(3):305-313. PubMed ID: 30713031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.